Does meal timing influence weight loss or metabolic health?: ASO webinar hosted by the Scotland Network
ASO and the Scotland Network are delighted to be hosting the first ASO webinar of 2021.
An international expert panel will present their latest research around the influence of time-restricted food intake on weight loss and metabolic health. In addition to comparing time restriction with calorie restriction for weight loss, in this webinar evidence will be presented on synchronising eating patterns with the biological clock, the safety of time-restricted feeding and how meal timing impacts on physical activity and energy expenditure. Scientific research will be put into perspective by our representative for people living with obesity who will present a patient perspective on the challenges and opportunities to change meal timing.
Speakers and Panellists
- Dr Abd Tahrani (University of Birmingham)
- Dr Anne Martin (University of Glasgow)
- Dr Emma Baldry (Senior Clinical Research Dietitian)
- Prof. Krista Varady (Department of Kinesiology and Nutrition, University of Illinois Chicago)
- Prof. Alex Johnstone (The Rowett Institute, University of Aberdeen)
- Dr Leonie Ruddick Collins (The Rowett Institute, University of Aberdeen)
- Prof. James Betts (University of Bath)
- Andrew Healing
This webinar has been accredited with 0.5 SCOPE Points, which count towards SCOPE Certification. SCOPE Certification is conferred by the World Obesity Federation and is the internationally recognised standard of excellence in obesity management. SCOPE Certification is awarded to health professionals with obesity management experience who have earned 12 SCOPE points. To receive your points you must have filled out the post event feedback survey. If you did not receive this please email ASOoffice@aso.org.uk and request a copy.
Novo Nordisk has provided sponsorship to the Association for the Study of Obesity (ASO) to fully fund all costs for the development of this webinar, including creation, organisation, production and administration. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ASO. None of the speakers have received a fee for their participation in this webinar, and ASO has been fully responsible for engaging with participants.